Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Bleomycin × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 9 Lymphoma 4 Neoplasms, Germ Cell and Embryonal 3 Vulvar Neoplasms 1 Teratoma 1 Seminoma 1 Neoplasms, Second Primary 1 Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hemangioma, Capillary 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 38 Dexamethasone 31 venetoclax 28 fludarabine 27 pembrolizumab 20 pomalidomide 17 Rituximab 17 Gemcitabine 16 Lenalidomide 14 Cytarabine 14 carfilzomib 11 Nivolumab 11 fludarabine phosphate 10 Temozolomide 10 Etoposide 10 Calcium Dobesilate 10 Azacitidine 10 glofitamab 9 daratumumab 9 Injections 9 obinutuzumab 8 Cisplatin 8 ibrutinib 7 cemiplimab 7 Carboplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡